Overview

Biosimulation Market Introduction: Biosimulation Market is predicted to value over USD 4 billion by 2027 end with a CAGR of over 15% during the forecast period 2020 to 2027. Bio-simulation is a distinct part of systems biology, which gives information about complex biological systems in disease and health. The bio-simulation is also referred to as in-silico biology, which means biological experiments have to carry out in the computer. It is an entirely new concept in the drug development industry, which relies on expressing the biological systems with mathematical expressions, thus, capturing biological elements and their relationships, and simulating the behaviour of certain systems in different situations. There are different types of bio-simulation approaches are available which gives outcome based on the complexity of biosystem and the disease- drug target. It credits the reduction and replacement of animal and human experimentations as well as improves the knowledge of how patients need to administer medicine. Biosimulation has a huge demand for drug development for mimicking disease indication. It is used to simulate the disease indication and decrease the effort of research. Increasing attrition rates of drug development have increased the dependence of research companies on simulation techniques for minimizing capital investments. Additionally, the rapid advancement of technologies has integrated the biosimulation process in clinical trials and offers complete automation. Biosimulation techniques also minimize human errors and increase the efficiency of the development process. Further, it also decreases the development time and speeds up the whole drug discovery process. All these factors led to robust growth of the market during the forecast period. Global Biosimulation market is expected to witness a high adoption rate due to increasing awareness of simulation techniques among the drug developing companies. North America market is expected to account major share in the global market due to high R&D investments of top drug manufacturers. It was followed by the European region and it also accounts significant share over the forecast period. It is expected to witness high growth rate over the forecast period. Both North America and Europe market is expected to remain dominant in the global market over the forecast period. The Asia Pacific, Latin America and Rest of the world market are expected to account a small fraction of market share due to less adoption. Biosimulation market players include: Certara, Simulations Plus, Dassault Systèmes, Schrödinger, ACD/Labs, Chemical Computing Group, Physiomics, Evidera, In silico biosciences, INOSIM Software, Insilico Biotechnology, LeadInvent Technologies, Rosa, Nuventra Pharma , and Genedata.



Biosimulation Market Segmentation: By Product & Service Software

Molecular Modeling and Simulation Software

PBPK Modeling and Simulation Software

PK/PD Modeling and Simulation Software

Trial Design Software

Toxicity Prediction Software

Other Biosimulation Software

Services

In-house Services

Contract Services By Application Drug Development

Drug Discovery

Other Applications By Delivery Model Subscription Models

Ownership Models By End User Pharmaceutical and Biotechnology Companies

Research Institutes

Contract Research Organizations

Regulatory Authorities

Other End Users By Region Europe

North America

APAC

Latin America

Rest of World Competitive Landscape: Tier 1 players- established companies in the market with a major market share

Tier 2 players

Emerging players which are growing rapidly

New Entrants FutureWise Takeaways: Growth prospects

SWOT analysis

Key trends

Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global market by product & service, by application, by delivery model, by end user and by region.

To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

To evaluate and forecast micro-markets and the overall market

To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement

• The customization Mobility Care offered are free of charge with purchase of any license of the report

• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com